Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 230-235 , April 2005

Pediatric aspects of diabetic kidney disease

  • Pascale H. Lane

      Affiliations

    • Corresponding Author InformationAddress correspondence to Pascale H. Lane, MD, 982169 Nebraska Medical Center, Omaha, NE 68198-2169.

References 

  1. Lane PH , Steffes MW , Mauer SM . The role of the pediatric nephrologist in the care of children with diabetes mellitus . Pediatr Nephrol . 1991;5:359–363
  2. Diabetes in Children Adolescents Work Group of the National Diabetes Education Program . An update on type 2 diabetes in youth from the National Diabetes Eduation Program . Pediatr . 2004;114:259–263
  3. Centers for Disease Control and Prevention . National Diabetes Fact Sheet (General Information and National Estimates on Diabetes in the United States, 2003) . Atlanta, GA: Centers for Disease Control and Prevention; 2004;
  4. Mogensen C , Christensen C , Vittinghus E . The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy . Diabetes . 1983;32(suppl 2):64–78
  5. US Renal Data System . USRDS 2004 Annual Data Report (Atlas of End-Stage Renal Disease in the United States) . Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004;
  6. Drummond K , Mauer SM  International Diabetic Nephropathy Study Group . The early natural history of nephropathy in type 1 diabetes. II. Early renal structural changes in type 1 diabetes . Diabetes . 2002;51:1580–1587
  7. Ellis EN , Warady BA , Wood EG , et al.   Renal structural-functional relationships in early diabetes mellitus . Pediatr Nephrol . 1997;11:584–591
  8. Mauer SM , Drummond K  International Diabetic Nephropathy Study Group . The early natural history of nephropathy in type 1 diabetes. I. Study design and baseline characteristics of the study participants . Diabetes . 2002;51:1572–1579
  9. Østerby R , Gundersen H . Glomerular size and structure in diabetes mellitus. I. Early abnormalities . Diabetologia . 1975;11:225–229
  10. Rudberg S , Osterby R . Diabetic glomerulopathy in young IDDM patients . Horm Res . 1998;50(suppl 1):17–22
  11. Work Group on Chronic Kidney Disease . National Kidney Foundation Kidney Disease Outcome Quality Initiative. Part 1. Executive Summary . Am J Kidney Dis . 2002;39(suppl 1):S17–S31
  12. American Diabetes Association . Standard of medical care in diabetes . Diabetes Care . 2004;27(suppl 1):S15–S35
  13. American Diabetes Association . Nephropathy in diabetes . Diabetes Care . 2004;27(suppl 1):S79–S83
  14. Lane PH . Diabetic kidney disease (Impact of puberty) . Am J Physiol Renal Physiol . 2002;283:F589–F600
  15. Donaghue K , Fairchild J , Chan A , et al.   Diabetes microvascular complications in prepubertal children . J Pediatr Endocrinol Metab . 1997;10:579–585
  16. Rudberg S , Dahlquist G . Determinants of progression of microalbuminuria in adolescents with IDDM . Diabetes Care . 1996;19:369–371
  17. Rudberg S , Ullman E , Dahlquist G . Relationship between early metabolic control and the development of microalbuminuria—A longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus . Diabetologia . 1993;36:1309–1314
  18. Schultz CJ , Konopelska-Bahu T , Dalton RN , et al.   Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study . Diabetes Care . 1999;22:495–502
  19. Comper WD , Osicka TM , Jerums G . High prevalence of immuno-unreactive intact albumin in urine of diabetic patients . Am J Kidney Dis . 2003;41:336–342
  20. Lane PH , Steffes MW , Mauer SM . Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion . Diabetes . 1992;41:581–586
  21. Tsalamandris C , Allen TJ , Gilbert RE , et al.   Progressive decline in renal function in diabetic patients with and without albuminuria . Diabetes . 1994;43:649–655
  22. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus . N Engl J Med . 1993;329:977–986
  23. Svensson M , Sundkvist G , Arnqvist HJ , et al.   Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management . Diabetes Care . 2003;26:2903–2909
  24. Svensson M , Eriksson JW , Dahlquist G . Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes . Diabetes Care . 2004;27:955–962
  25. American Diabetes Association . Diabetic nephropathy . Diabetes Care . 2002;25(suppl 1):S85–S89
  26. Lewis EJ , Hunsicker LG , Bain RP , et al.  Collaborative Study Group   The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy . N Engl J Med . 1993;329:1456–1462
  27. Rudberg S , Osterby R , Bangstad H-J , et al.   Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus . Diabetologia . 1999;42:589–595
  28. Mogensen CE , Hansen KW , Pedersen MM , et al.   Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM . Diabetes Care . 1991;14(suppl 4):13–26
  29. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents . The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents . Pediatr . 2004;114:555–576
  30. Lane JT . Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus (A temporal perspective) . Am J Physiol Renal Physiol . 2004;286:F442–F450
  31. Marchesini G , Forlani G , Cerrelli F , et al.   WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes . Diabet Med . 2004;21:383–387
  32. Ritz E , Orth SR . Nephropathy in patients with type 2 diabetes mellitus . N Engl J Med . 1999;341:1127–1133
  33. Hasslacher C , Ritz E , Wahl P , et al.   Similar risks of nephropathy in patients with type I or type II diabetes mellitus . Nephrol Dial Transplant . 1989;4:859–863
  34. Fioretto P , Mauer S , Brocco E , et al.   Patterns of renal injury in NIDDM patients with microalbuminuria . Diabetologia . 1996;39:1569–1576
  35. Dean H , Flett B . Natural history of type 2 diabetes diagnosed in childhood (Long term follow-up in young adult years) . Diabetes . 2002;51(suppl 2):A25–A26
  36. Mitch WE . Treating diabetic nephropathy—Are there only economic issues? . N Engl J Med . 2004;351:1934–1936
  37. Barnett AH , Bain SC , Bouter P , et al.  Diabetics Exposed to Telmisartan and Enalapril Study Group   Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy . N Engl J Med . 2004;351:1952–1961
  38. Brenner BM , Cooper ME , deZeeuw D , et al.  RENAAL Study Investigators   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy . N Engl J Med . 2001;345:861–869
  39. Lewis EJ , Hunsicker LG , Clarke WR , et al.  Collaborative Study Group   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes . N Engl J Med . 2001;345:851–860
  40. Ruggenenti P , Fassi A , Parvanova Ilieva A , et al.  Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators   Preventing microalbuminuria in type 2 diabetes . N Engl J Med . 2004;351:1941–1951

 Supported in part by grant R01 DK059869.

PII: S1548-5595(05)00029-7

doi: 10.1053/j.ackd.2005.01.005

Advances in Chronic Kidney Disease
Volume 12, Issue 2 , Pages 230-235 , April 2005

Article Tools

* Image Usage & Resolution